Samsung Electronics and Massachusetts General Hospital (MGH) Diabetes Research Center (DRC) at the moment collectively introduced a analysis examine to research the efficacy of Galaxy Watch in helping adults beginning GLP-1RA1 remedy to watch and doubtlessly handle muscle loss. With almost one in 5 adults within the US saying they’ve taken GLP-1 treatment, this revolutionary medical examine will examine how steady knowledge from Galaxy Watch can assist sufferers and clinicians monitor and mitigate muscle loss by offering a clearer, extra holistic view of an individual’s physique composition and exercise ranges throughout therapy.
As GLP-1 medicines change into broadly adopted for weight administration and power illness therapy, monitoring adjustments in muscle mass and bodily exercise alongside weight reduction has emerged as a key medical focus. This analysis will delve into the feasibility of managing muscle loss for GLP-1 sufferers by using biometric knowledge together with physique composition, exercise ranges and coronary heart price offered by Galaxy Watch and Samsung Health.
Samsung and MGH have repeatedly collaborated on digital well being analysis using each Galaxy Watch and Samsung Health, together with research on Advanced Glycation End Products (AGEs). The MGH Diabetes Research Center, which focuses on analysis on diabetes and GLP-1 weight problems therapy, initiated the joint examine with Samsung after recognizing the potential for wearables to watch physique composition.
This examine may even make the most of Galaxy Watch8, powered by Samsung’s groundbreaking BioActive Sensor,2 which helps present superior predictive and preventative wellness by means of extra correct well being measurements.
Under the management of Dr. Melissa Putman, the examine will enroll 100 adults starting therapy with weight-loss medicines into two teams. The intervention group will use Galaxy Watch to watch their physique composition through Bioelectrical Impedance Analysis (BIA), monitor bodily exercise and obtain customized train guides. Their progress can be in comparison with the opposite group, which can obtain the usual steering and care usually given to sufferers beginning GLP-1RA remedy.
To consider the examine’s progress, researchers will use clinical-grade DXA scans3 — the gold commonplace for physique composition evaluation — to trace physiological adjustments in each teams. These knowledge will assist decide whether or not the insights and tailor-made steering offered by Galaxy WatchEight can successfully assist individuals in constructing more healthy each day habits, which can in flip contribute to higher well being outcomes notably in preserving muscle mass.
“Many GLP-1 patients struggle with muscle mass loss, a common side effect that can cause an increased risk of cardiovascular disease and a drop in basal metabolic rate, which can lead to future weight regain,” stated Dr. Putman, Director of the MGH Diabetes Research Center. “We’re interested in exploring how continuous data from a wearable device can provide invaluable insights into a patient’s activity levels, heart rate and body composition, giving clinicians a more holistic view of treatment impact and allowing for more timely, data-driven adjustments to their care plan.”
“This collaboration with MGH focuses on addressing real-world health challenges that patients face during GLP-1RA therapy, specifically managing muscle loss and building healthy habits,” stated Jongmin Choi, Head of Health R&D Group, Mobile eXperience (MX) Business, Samsung Electronics. “Ultimately, this study highlights Samsung’s ongoing commitment to delivering comprehensive and proactive health management solutions through the advanced capabilities of Galaxy Watch.”
Samsung stays dedicated to researching how Galaxy Watch can assist sufferers in managing their each day bodily well being. By fostering sustainable wellness habits, the corporate goals to assist sufferers obtain higher medical outcomes and long-term vitality.
Samsung continues to…
